Is It Possible to Delay or Prevent Age-Related Cognitive Decline?
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Already in the 90s, Khachaturian stated that postponing dementia onset by five years would decrease the preva-lence of the late onset dementia by 50%. After two decades of lack of success in dementia drug discovery and devel-opment, and knowing that worldwide, currently 36 million patients have been diagnosed with Alzheimer’s disease, a number that will double by 2030 and triple by 2050, the World Health Organization and the Alzheimer’s Disease International declared that prevention of cognitive decline was a ‘public health priority.’ Numerous longitudinal studies and meta-analyses were conducted to analyze the risk and protective factors for dementia. Among the 93 identified risk factors, seven major modifiable ones should be considered: low education, sedentary lifestyle, midlife obesity, midlife smoking, hypertension, diabetes, and midlife depression. Three other important modifi-able risk factors should also be added to this list: midlife hypercholesterolemia, late life atrial fibrillation, and chronic kidney disease. After their identification, numerous authors attempted to establish dementia risk scores; however, the proposed values were not convincing. Identifying the possible interventions, able to either postpone or delay dementia has been an important challenge. Observational studies focused on a single life-style interven-tion increased the global optimism concerning these possibilities. However, a recent extensive literature review of the randomized control trials (RCTs) conducted before 2014 yielded negative results. The first results of RCTs of multimodal interventions (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, Multidomain Alzheimer Prevention Study, and Prediva) brought more optimism. Lastly, interventions targeting compounds of beta amyloid started in 2012 and no results have yet been published.
Abstract
Already in the 90s, Khachaturian stated that postponing dementia onset by five years would decrease the preva-lence of the late onset dementia by 50%. After two decades of lack of success in dementia drug discovery and devel-opment, and knowing that worldwide, currently 36 million patients have been diagnosed with Alzheimer’s disease, a number that will double by 2030 and triple by 2050, the World Health Organization and the Alzheimer’s Disease International declared that prevention of cognitive decline was a ‘public health priority.’ Numerous longitudinal studies and meta-analyses were conducted to analyze the risk and protective factors for dementia. Among the 93 identified risk factors, seven major modifiable ones should be considered: low education, sedentary lifestyle, midlife obesity, midlife smoking, hypertension, diabetes, and midlife depression. Three other important modifi-able risk factors should also be added to this list: midlife hypercholesterolemia, late life atrial fibrillation, and chronic kidney disease. After their identification, numerous authors attempted to establish dementia risk scores; however, the proposed values were not convincing. Identifying the possible interventions, able to either postpone or delay dementia has been an important challenge. Observational studies focused on a single life-style interven-tion increased the global optimism concerning these possibilities. However, a recent extensive literature review of the randomized control trials (RCTs) conducted before 2014 yielded negative results. The first results of RCTs of multimodal interventions (Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, Multidomain Alzheimer Prevention Study, and Prediva) brought more optimism. Lastly, interventions targeting compounds of beta amyloid started in 2012 and no results have yet been published.
참고문헌 (22)
- Khachaturian ZS, "A proposed strategy for international collaborative research in brain aging and Alzheimer’s disease", Int J Clin Pharmacol Res, 10, pp.3~5 (1990)
- Gauthier S, "Why has therapy development for dementia failed in the last two decades?", Alzheimers Dement, 12, pp.60~64 (2016)
- "Alzheimer’s Disease International. Dementia:a public health priority" (2012)[URL]
- Satizabal CL, "Incidence of dementia over three decades in the Framingham Heart Study", N Engl J Med, 374, pp.523~532 (2016)
- Jones DS, "Is dementia in decline?: historical trends and future trajectories", N Engl J Med, 374, pp.507~509 (2016)
- Xu W, "Meta-analysis of modifiable risk factors for Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 86, pp.1299~1306 (2015)
- Norton S, "Potential for primary prevention of Alzheimer’s disease: an analysis of populationbased data", Lancet Neurol, 13, pp.788~794 (2014)
- Deckers K, "Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies", Int J Geriatr Psychiatry, 30, pp.234~246 (2015)
- Kivipelto M, "Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study", BMJ, 322, pp.1447~1451 (2001)
- Rusanen M, "Heart diseases and long-term risk of dementia and Alzheimer’s disease: a population-based CAIDE study", J Alzheimers Dis, 42, pp.183~191 (2014)
- Etgen T, "Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis", Am J Nephrol, 35, pp.474~482 (2012)
- Kivipelto M, "Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study", Lancet Neurol, 5, pp.735~741 (2006)
- Exalto LG, "Midlife risk score for the prediction of dementia four decades later", Alzheimers Dement, 10, pp.562~570 (2014)
- Kaffashian S, "Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores", Neurology, 80, pp.1300~1306 (2013)
- Van Gool WA, "Can we prevent, delay, or shorten the course of dementia?", PLoS Med, 3, pp.e430~ (2006)
- Andrieu S, "Prevention of sporadic Alzheimer’s disease: lessons learned from clinical trials and future directions", Lancet Neurol, 14, pp.926~944 (2015)
- Kalmijn S, "Dietary fat intake and the risk of incident dementia in the Rotterdam Study", Ann Neurol, 42, pp.776~782 (1997)
- Pu S, "Association between fish consumption and prefrontal function during a cognitive task in male Japanese workers: a multi-channel near-infrared spectroscopy study", PLoS One, 10, pp.e0123972~ (2015)
- Sofi F, "Physical activity and risk of cognitive decline: a meta-analysis of prospective studies", J Intern Med, 269, pp.107~117 (2011)
- Martinez-Lapiscina EH, "Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial", J Neurol Neurosurg Psychiatry, 83, pp.1318~1325 (2013)
- Sindi S, "Advances in the prevention of Alzheimer’s disease", F1000Prime Rep, 7, pp.50~ (2015)
- Ngandu T, "A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomized controlled trial", Lancet, 385, pp.2255~2263 (2015)